Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: Where are we for cholesterol gallstone formation?^†‡

• Pages: 1313-1316
• First Published: 23 January 2012

• Pages: 1317-1323
• First Published: 02 December 2011

Suppression of interferon-α signaling by hepatitis E virus^†

• Pages: 1324-1332
• First Published: 20 December 2011

The cyclophilin inhibitor alisporivir prevents hepatitis C virus–mediated mitochondrial dysfunction^†

• Pages: 1333-1343
• First Published: 02 December 2011

Economic model of a birth cohort screening program for hepatitis C virus^†‡

• Pages: 1344-1355
• First Published: 02 December 2011

Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice^†

• Pages: 1356-1368
• First Published: 26 November 2011

Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease^†

• Pages: 1369-1378
• First Published: 20 December 2011

Retinoic acid receptor–related orphan receptor α–induced activation of adenosine monophosphate–activated protein kinase results in attenuation of hepatic steatosis^†‡

• Pages: 1379-1388
• First Published: 20 December 2011

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease^†

• Pages: 1389-1397
• First Published: 20 December 2011

Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from the UNOS database^†

• Pages: 1398-1405
• First Published: 24 December 2011

Fatty liver index, gamma-glutamyltransferase, and early carotid plaques^†‡

• Pages: 1406-1415
• First Published: 15 February 2012

Family history of liver cancer and hepatocellular carcinoma^†

• Pages: 1416-1425
• First Published: 16 November 2011

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development^†

• Pages: 1426-1431
• First Published: 22 November 2011

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patients^†

• Pages: 1432-1442
• First Published: 23 November 2011

Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma^†

• Pages: 1443-1452
• First Published: 22 November 2011

Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis^†‡§

• Pages: 1453-1461
• First Published: 02 December 2011

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus^†‡

• Pages: 1462-1472
• First Published: 02 December 2011

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis^†‡

• Pages: 1473-1484
• First Published: 23 January 2012

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase–signaling pathway ^†‡

• Pages: 1485-1494
• First Published: 22 November 2011

Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody–positive versus antimitochondrial autoantibody–negative primary biliary cirrhosis^†

• Pages: 1495-1506
• First Published: 02 December 2011

Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease^†

• Pages: 1507-1517
• First Published: 27 December 2011

Toll-like receptor 4–dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury^†‡

• Pages: 1518-1528
• First Published: 26 November 2011

The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis^†

• Pages: 1529-1539
• First Published: 23 November 2011

Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats^†

• Pages: 1540-1550
• First Published: 20 December 2011

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study^†

• Pages: 1551-1561
• First Published: 20 December 2011

Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice^†

• Pages: 1562-1573
• First Published: 22 November 2011

Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: Implications for liver regeneration^†

• Pages: 1574-1584
• First Published: 22 November 2011

Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice^†

• Pages: 1585-1595
• First Published: 22 November 2011

Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice^†‡

• Pages: 1596-1609
• First Published: 24 December 2011

Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice^†‡

• Pages: 1610-1619
• First Published: 12 January 2012

Review and management of drug interactions with boceprevir and telaprevir^†‡

• Pages: 1620-1628
• First Published: 13 February 2012

Transient elastography and prognosis of cirrhosis^†‡

• Pages: 1629-1631
• First Published: 19 April 2012

Transcription factor EB: A central regulator of both the autophagosome and lysosome^†

• Pages: 1632-1634
• First Published: 19 April 2012

Dismantling the myth of “autoanticoagulation” in cirrhosis: An old dogma dies hard^†

• Pages: 1634-1637
• First Published: 19 April 2012

Distal common bile duct metastasis from hepatocellular carcinoma^†

• Pages: 1638-1639
• First Published: 26 November 2011

Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection^†

• Page: 1640
• First Published: 11 July 2011

Reply^†

• Page: 1640
• First Published: 16 March 2012

Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer^†‡

• Pages: 1640-1642
• First Published: 27 December 2011

Reply^†

• Pages: 1642-1643
• First Published: 27 December 2011

Hepatitis E virus-specific T-cell response after transplantation^†

• Page: 1643
• First Published: 11 January 2012

Reply^†

• Page: 1644
• First Published: 04 January 2012

Prioritizing treatment experienced patients with hepatitis C infection for treatment with telaprevir: A number needed to treat approach^†

• Pages: 1644-1645
• First Published: 27 December 2011

Effect of interleukin-28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with pegylated interferon alpha-2a/ribavirin^†

• Page: 1645
• First Published: 27 December 2011